Mirae Asset Global Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $112K | Buy |
|
|||||
|
2025
Q2 | $133K | Buy |
|
|||||
|
2025
Q1 | $117K | Buy |
|
|||||
|
2024
Q4 | $134K | Sell |
|
|||||
|
2024
Q3 | $181K | Buy |
|
|||||
|
2024
Q2 | $103K | Sell |
|
|||||
|
2024
Q1 | $8.76M | Buy |
|
|||||
|
2023
Q4 | $5.18M | Sell |
|
|||||
|
2023
Q3 | $7.52M | Buy |
|
|||||
|
2023
Q2 | $8.87M | Sell |
|
|||||
|
2023
Q1 | $9.35M | Buy |
|
|||||
|
2022
Q4 | $10.4M | Buy |
|
|||||
|
2022
Q3 | $5.49M | Buy |
|
|||||
|
2022
Q2 | $7.64M | Sell |
|
|||||
|
2022
Q1 | $9.94M | Sell |
|
|||||
|
2021
Q4 | $13.5M | Buy |
|
|||||
|
2021
Q3 | $11.1M | Buy |
|
|||||
|
2021
Q2 | $9.76M | Buy |
|
|||||
|
2021
Q1 | $10M | Buy |
|
|||||
|
2020
Q4 | $7.56M | Buy |
|
|||||
|
2020
Q3 | $3.64M | Buy |
|
|||||
|
2020
Q2 | $2.48M | Buy |
|
|||||
|
2020
Q1 | $943K | Buy |
|
|||||
|
2019
Q4 | $811K | Buy |
|
|||||
|
2019
Q3 | $463K | Buy |
|
|||||
|
2019
Q2 | $241K | Buy |
|